Injecto Polymers is an SME IPO scheduled to open on 11 Sept 2026 and close on 16 Sept 2026, priced at ₹98 – ₹100 per share, minimum lot 1,200 shares (~₹2,40,000 for retail). Proposed listing on NSE, BSE on 21 Sept 2026.
About Injecto Polymers
Injecto Polymers manufactures and trades plastic packaging products, specializing in high-denier fabrics tailored for heavy-duty applications. The company’s core product portfolio encompasses flexible intermediate bulk containers (FIBC), woven sacks, and bags utilized for packaging fertilizers, cement, food grains, and seeds. Operating out of two manufacturing facilities in West Bengal with a combined installed capacity of 10,870 metric tonnes, the business primarily serves customers in eastern India. Injecto Polymers generates revenue through a combination of manufacturing and trading operations, sourcing raw materials like polypropylene granules, high-density polyethylene, and low-density polyethylene from both domestic and international markets. The company caters to the agriculture, construction, textiles, and chemicals sectors, managing its supply chain through a flexible, order-based sales model designed to adapt to fluctuating customer demand and optimize operational scale.
Injecto Polymers IPO Details
| IPO Type | SME |
| Price Band | ₹98 – ₹100 per share |
| Lot Size | 1,200 shares · ~₹2,40,000 for retail |
| Grey Market Premium (GMP) | Not available yet |
| Total Issue Size | ₹56.12 crore |
| Listing At | NSE, BSE |
Injecto Polymers IPO Important Dates
| Event | Date |
|---|---|
| IPO Open Date | 11 Sept 2026 |
| IPO Close Date | 16 Sept 2026 |
| Basis of Allotment | 17 Sept 2026 |
| Refund / UPI Mandate Release | 18 Sept 2026 |
| Credit of Shares to Demat | 18 Sept 2026 |
| Listing Date | 21 Sept 2026 |
Injecto Polymers IPO Lot Size & Investment
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail | 2 | 2,400 | ₹2,40,000 |
| HNI | 3 – 8 | 3,600 – 9,600 | ₹3,60,000 – ₹9,60,000 |
Injecto Polymers IPO GMP (Grey Market Premium)
The latest grey market premium for Injecto Polymers is Not available yet. GMP is an unofficial, over-the-counter figure that can change through the day and is not endorsed by SEBI or the exchanges.
Injecto Polymers — Strengths
- Phase IV expansion directly scales core manufacturing capacity.
- Debt repayment will improve overall leverage and financial health.
- Strong market foothold across the eastern Indian packaging sector.
- Proven capability to produce heavy-duty, high-denier fabrics.
- Solar power infrastructure reduces reliance on the state grid.
Injecto Polymers — Risks
- Phase IV capital expenditure is subject to execution and cost risks.
- Restrictive debt covenants currently limit our operational flexibility.
- Top 5 customers generate over 30% of total operating revenue.
- Heavy reliance on lower-margin trading activities impacts profits.
- Negative operating cash flows constrain future working capital.
Injecto Polymers IPO Objects of the Issue
| Purpose | Amount (₹ crore) |
|---|---|
| Capital Expenditure | 30.5 (54.35%) |
| Repayment Of Borrowings | 10 (17.82%) |
| General Corporate Purpose | 15.62 (27.83%) |
Injecto Polymers IPO Prospectus
Read the offer document: Injecto Polymers DRHP / RHP (PDF).
More on Injecto Polymers IPO
- Injecto Polymers IPO — live GMP, subscription & allotment status
- Injecto Polymers IPO listing gain calculator
- All SME IPOs
- Full IPO list with GMP
Allotment and listing-gain details will be published here once available. This article is for information only and is not investment advice. Read the RHP and consider your own risk profile before investing.
Loading comments...